Bausch Health (BHC:NYSE) Annual Reports & Investor Relations Material

Overview

Bausch Health Companies Inc., a pharmaceutical and medical device maker, is the developer of eye health, gastroenterology, and dermatology products. The company operates through five segments - Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States, while the International segment offers Solta products, as well as branded and generic pharmaceutical products, OTC products, and medical device products across Canada, Europe, Asia, Latin America, Africa, and the Middle East. Meanwhile, the Diversified Products segment offers neurology and other therapeutic classes, as well as generic, dermatological, and dentistry products in the US. Lastly, the Bausch + Lomb segment focuses on vision care, surgical, and ophthalmic pharmaceuticals products. Bausch Health Companies Inc. was previously known as Valeant Pharmaceuticals International, Inc. before changing to its current name in July 2018. The company is headquartered in Laval, Canada.

Frequently Asked Questions

What is Bausch Health's ticker?

Bausch Health's ticker is BHC

What exchange is Bausch Health traded on?

The company's shares trade on the NYSE stock exchange

Where are Bausch Health's headquarters?

They are based in Laval, Quebec

How many employees does Bausch Health have?

There are 10,000+ employees working at Bausch Health

What is Bausch Health's website?

It is bauschhealth.com

What type of sector is Bausch Health?

Bausch Health is in the Healthcare sector

What type of industry is Bausch Health?

Bausch Health is in the Drug Manufacturers - Other industry

Who are Bausch Health's peers and competitors?

The following five companies are Bausch Health's industry peers:

- Cumberland Pharmaceuticals Inc

- MYOS RENS Technology Inc.

- Aphria

- Athenex

- Regenerx Biopharmaceuticals Inc.